GC
FLNA

GMT Capital’s Filana Therapeutics FLNA Stock Holding History

GMT Capital’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$761K Buy
+450,100
New +$927K 0.03% 60
2025
Q4 		– Sell
-450,100
Closed -$1.31M – 62
2025
Q3 		$1.31M Hold
450,100
– – 0.06% 51
2025
Q2 		$815K Hold
450,100
– – 0.03% 58
2025
Q1 		$675K Buy
+450,100
New +$1.14M 0.04% 58
2022
Q4 		– Sell
-115,100
Closed -$4.81M – 91
2022
Q3 		$4.81M Buy
+115,100
New +$3.11M 0.3% 50

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GMT Capital's FLNA Position: Q1 2026 in Review

GMT Capital opened a new position in Filana Therapeutics (FLNA) in Q1 2026: 450,100 shares worth $761K. The stake represents 0.03% of the portfolio and ranks #60 among its holdings. This is a return to the name: GMT Capital previously reported a position in FLNA as recently as Q3 2025.

GMT Capital first reported a position in FLNA in Q3 2022 and has held it in 5 quarters since. The position peaked at $4.81M in Q3 2022. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • GMT Capital held 450,100 shares of Filana Therapeutics worth $761K as of Q1 2026.
  • Filana Therapeutics was a new GMT Capital position in Q1 2026.
  • Filana Therapeutics made up 0.03% of GMT Capital's portfolio in Q1 2026, its #60 holding.
  • GMT Capital first reported a position in Filana Therapeutics in Q3 2022 and has held it in 5 quarters since.
  • GMT Capital's Filana Therapeutics position peaked at $4.81M in Q3 2022.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on GMT Capital's 13F filing for Q1 2026, filed 15 May 2026.